Korean J Hepatobiliary Pancreat Surg.
2004 Jun;8(2):85-91.
Collective Analysis of Surgical Results in the Patients with Pancreatic Cancer from 4 Major Hospitals
- Affiliations
-
- 1Department of Surgery, Seoul National University College of Medicine, Korea. sunkim@snu.ac.kr
- 2Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea.
- 3Department of Surgery, Ulsan University College of Medicine & Asan Medical Center, Korea.
- 4Department of Surgery, Yonsei University College of Medicine, Korea.
Abstract
- PURPOSE
Despite the many advances in medical diagnosis and treatment, the prognosis of a pancreatic ductal adenocarcinoma is still poor. The objectives of this study were to evaluate the clinical results of a pancreatectomy for treating pancreatic cancer in Korea, and investigate whether or not there was an improvement in the survival rate over time. METHODS: From 1990 to 2002, 4278 patients with pancreatic cancer from 4 hospitals (Seoul National University Hospital, Samsung Medical Center, Asan Medical Center, Severance Hospital) were enrolled in this study. We retrospectively reviewed the clinico-pathological data of the 566 patients who underwent surgical resection and analyzed clinical results according to the time intervals (1990~1996 vs. 1997~2002). RESULTS: The median survival rate of the patients underwent a resection was 14.1 months with 14.3% of 5 year survival rate (5 YSR). Univariate analysis showed that the tumor size, the depth of invasion, lymph node metastasis, AJCC stage, portal vein resection, and adjuvant chemotherapy were the prognostic factors. Multivariate analysis showed that the tumor size, lymph node metastasis, and adjuvant chemotherapy were significant. There was a survival difference according to the time interval (11.0 vs. 15.4% in 5 YSR). A small tumor size and a low AJCC as well as active adjuvant therapy affected this survival increment. CONCLUSION: There was a slightly higher survival rate of pancreatic cancer after resection recently. This was mainly due to the early diagnosis and adjuvant therapy. Although pancreatic cancer is still lethal, progress in new systemic treatment and early detection method shows promise in the management of pancreatic cancer.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Effects of Self-efficacy and Collective Efficacy on Job Satisfaction and Organizational Commitment of Nurses
- Surgical management for elderly patients with pancreatic cancer
- Impact of Surgery on Oligometastatic Pancreatic Cancer: Current Status and Future Perspectives
- The Risk Factors of Pancreatic Fistula after Pancratoduodenectomy
- Genomic Landscapes of Pancreatic Neoplasia
